Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gossamer Bio, Inc. - Common Stock (NQ:GOSS)

0.2101 +0.0092 (+4.58%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,800,483
Open 0.1996
Bid (Size) 0.2155 (700)
Ask (Size) 0.2159 (1,700)
Prev. Close 0.2009
Today's Range 0.1955 - 0.2119
52wk Range 0.1626 - 3.870
Shares Outstanding 75,993,532
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire

Performance

YTD
-92.7%
-92.7%
1 Month
-39.7%
-39.7%
3 Month
-50.4%
-50.4%
6 Month
-93.4%
-93.4%
1 Year
-81.2%
-81.2%

More News

Read More
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines – GOSS
From Pomerantz LLP
Via GlobeNewswire
These stocks are moving in today's session ↗
Via Chartmill
News headline image
GOSS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Gossamer Bio (GOSS) Investors of Securities Class Action Deadline on June 1, 2026
From Faruqi & Faruqi, LLP
Via Business Wire
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Via Chartmill
News headline image
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
Which stocks are gapping on Monday? ↗
Via Chartmill
News headline image
Gossamer Bio Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Gossamer Bio, Inc. Launches Exchange Offer and Consent Solicitation Intended to Eliminate Over $120 Million of Debt with Existing Noteholder Support
From Gossamer Bio, Inc.
Via Business Wire
News headline image
Gossamer Bio Announces First Quarter 2026 Financial Results and Provides Business Update
From Gossamer Bio, Inc.
Via Business Wire
News headline image
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Gossamer Bio to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 18, 2026
From Gossamer Bio, Inc.
Via Business Wire
News headline image
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GOSS
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines – GOSS
From Pomerantz LLP
Via GlobeNewswire
News headline image
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Gossamer Investors that a Class Action Lawsuit Has Been Filed Against Gossamer Bio, Inc. (NASDAQ:GOSS) and Encourages Investors with Large Losses to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Gossamer Bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GOSS
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Gossamer Bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GOSS
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Gossamer Bio, Inc. of Class Action Lawsuit and Upcoming Deadlines – GOSS
From Pomerantz LLP
Via GlobeNewswire
News headline image
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
INVESTOR REMINDER: Berger Montague Notifies Gossamer Bio, Inc. (NASDAQ: GOSS) Investors of a Class Action Lawsuit and Deadline
From Berger Montague
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Gossamer Investors that a Class Action Lawsuit Has Been Filed Against Gossamer Bio, Inc. (NASDAQ:GOSS) and Encourages Investors with Large Losses to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire

Frequently Asked Questions

Is Gossamer Bio, Inc. - Common Stock publicly traded?
Yes, Gossamer Bio, Inc. - Common Stock is publicly traded.
What exchange does Gossamer Bio, Inc. - Common Stock trade on?
Gossamer Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Gossamer Bio, Inc. - Common Stock?
The ticker symbol for Gossamer Bio, Inc. - Common Stock is GOSS on the Nasdaq Stock Market
What is the current price of Gossamer Bio, Inc. - Common Stock?
The current price of Gossamer Bio, Inc. - Common Stock is 0.2101
When was Gossamer Bio, Inc. - Common Stock last traded?
The last trade of Gossamer Bio, Inc. - Common Stock was at 05/22/26 04:00 PM ET
What is the market capitalization of Gossamer Bio, Inc. - Common Stock?
The market capitalization of Gossamer Bio, Inc. - Common Stock is 15.97M
How many shares of Gossamer Bio, Inc. - Common Stock are outstanding?
Gossamer Bio, Inc. - Common Stock has 16M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.